Roa Dueñas Oscar H, Xu Yanning, Ikram Mohammad Arfan, Peeters Robin P, Visser Edward, Chaker Layal
Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, the Netherlands; Department of Internal Medicine, Academic Center for thyroid diseases, Erasmus University Medical Center, Rotterdam, the Netherlands.
Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Endocr Pract. 2025 Feb;31(2):198-207. doi: 10.1016/j.eprac.2024.11.011. Epub 2024 Dec 2.
Although often enquired about by patients, the association of thyroid function with anthropometric measures in the general population is unclear. We summarized population-based studies and randomized controlled trials (RCTs) on the association between thyroid function and anthropometric measures.
We systematically searched Embase, Medline (Ovid), and Cochrane Central Register of Controlled Trials from inception until June 28, 2023. We included studies in adults examining thyroid function or thyroid disease as exposure and anthropometric measures as outcome (eg, body mass index [BMI], weight). We used random effect meta-analyses to pool the results.
We included 64 studies in the qualitative synthesis, and 21 in the quantitative synthesis (total participants n = 107 734 for cross-sectional studies, n = 22 010 for longitudinal studies, n = 80 for RCTs). The evidence was limited and heterogeneous, particularly for longitudinal studies. Cross-sectionally, we described an association for thyroid-stimulating hormone (TSH) concentrations and BMI (B per 1 mIU/L increase of TSH = 0.21; 95% confidence interval [CI], 0.09-0.32) and for free thyroxine (FT4) and BMI (B = -0.14; 95% CI, -0.23 to -0.05). Longitudinally, increasing TSH concentrations were related to weight gain and increasing FT4 concentrations to weight loss.
We showed a relation between higher TSH concentrations and higher BMI or weight, and between higher FT4 concentrations and lower BMI or weight, although effect sizes were modest. We highlight the need of more high-quality longitudinal studies. Despite the relevance of the association between thyroid (dys-)function and anthropometric measures, evidence is scarce.
尽管患者经常询问,但甲状腺功能与普通人群人体测量指标之间的关联尚不清楚。我们总结了基于人群的研究以及关于甲状腺功能与人体测量指标之间关联的随机对照试验(RCT)。
我们系统检索了从创刊至2023年6月28日的Embase、Medline(Ovid)和Cochrane对照试验中央注册库。我们纳入了以成年人作为研究对象的研究,这些研究将甲状腺功能或甲状腺疾病作为暴露因素,将人体测量指标作为结局(例如,体重指数[BMI]、体重)。我们使用随机效应荟萃分析来汇总结果。
我们在定性综合分析中纳入了64项研究,在定量综合分析中纳入了21项研究(横断面研究的总参与者n = 107734,纵向研究的n = 22010,RCT的n = 80)。证据有限且存在异质性,尤其是纵向研究。横断面分析中,我们描述了促甲状腺激素(TSH)浓度与BMI之间的关联(TSH每升高1 mIU/L,B = 0.21;95%置信区间[CI],0.09 - 0.32)以及游离甲状腺素(FT4)与BMI之间的关联(B = -0.14;95% CI,-0.23至-0.05)。纵向分析中,TSH浓度升高与体重增加有关,FT4浓度升高与体重减轻有关。
我们发现较高的TSH浓度与较高的BMI或体重之间存在关联,较高的FT4浓度与较低的BMI或体重之间存在关联,尽管效应量较小。我们强调需要更多高质量的纵向研究。尽管甲状腺(功能异常)与人体测量指标之间的关联具有相关性,但证据仍然不足。